Fetch session spotlights stage-based wound care strategies
Bottom line
A new dvm360 conference recap from Fetch Kansas City highlights a practical, stage-based approach to wound management in dogs and cats, with a focus on matching treatment to the biology of healing rather than relying on a one-size-fits-all protocol. The October 8, 2026, piece summarizes a CE session led by Kelly Sovey, DVM, CVA, and others, covering the four stages of wound repair — inflammatory, debridement, proliferative, and remodeling — and when clinicians should shift from traditional closure or second-intention healing plans to more advanced options. The session also emphasized recognizing stalled wounds, selecting stage-appropriate dressings, and supporting recovery at home through stronger pet parent adherence. (dvm360.com)
Why it matters: For veterinary professionals, the message is less about a single new product and more about decision-making discipline. The Fetch session underscored that wound care is dynamic, especially in chronic, contaminated, or structurally complex cases, and that dressing choice, moisture balance, debridement strategy, and bandage technique all need to change as the wound evolves. That aligns with broader guidance from the MSD Veterinary Manual, which notes that different dressing classes serve different functions, from adding moisture in dry wounds to absorbing exudate or shortening the inflammatory phase, while poor bandage selection or application can create complications of its own. (dvm360.com)
What to watch: Expect continued attention on how advanced matrices, microcurrent dressings, and other adjunctive tools fit into everyday small animal wound care, especially if companies and CE partners begin publishing stronger comparative outcomes data. (scafigen.com)
Key facts
- Topic
- Stage-based wound management in dogs and cats
- Source
- dvm360 Fetch Kansas City conference recap
- Publication date
- October 8, 2026
- Wound repair stages
- Inflammatory, debridement, proliferative, and remodeling
- Clinical focus
- Match treatment to the biology of healing
- Treatment decisions
- When to close, when to use second-intention healing, and when to escalate to advanced modalities
- Adjunctive tools mentioned
- 3D extracellular matrix hydrogel, microcurrent dressings
- Home care emphasis
- Pet parent adherence, bandage care, and recheck timing
A Fetch Kansas City session now recapped by dvm360 is putting renewed attention on a familiar clinical challenge: wound care that doesn’t progress in a straight line. Published October 8, 2026, the article outlines an evidence-based framework for managing wounds through the four stages of repair — inflammatory, debridement, proliferative, and remodeling — while helping clinicians decide when to close, when to let a wound heal by second intention, and when to escalate to advanced modalities. (dvm360.com)
That emphasis reflects a broader shift in veterinary wound management toward phase-specific care rather than static protocols. dvm360’s summary describes the session as a roadmap for both acute injuries and chronic, nonhealing wounds, with attention to clinical markers of stagnation and to the practical realities of long recoveries outside the hospital. The article also frames pet parent adherence as part of the treatment plan, not an afterthought, which is notable in cases where bandage care, recheck timing, and home monitoring can determine whether a wound progresses or stalls. (dvm360.com)
The session appears to have blended core wound-healing principles with newer commercial and procedural adjuncts. dvm360 says the discussion included decisions around closure versus second-intention healing, appropriate dressings for stalled wounds, patientwide supportive care, and use of a 3D extracellular matrix hydrogel. A related Vet Blast podcast episode from July 30, 2026, featuring Kelly Sovey, DVM, CVA, and Karl C. Maritato, DVM, DACVS-SA, says the conversation covered chronic non-healing wounds, dead space, degloving injuries, and a product called ScafiGen, which the speakers said could improve outcomes and pet parent compliance in practice. (dvm360.com)
Additional company materials provide some context on that product, though not independent clinical validation. ScafiGen’s website describes it as a hydrated 3D hydrogel matrix designed to conform to wound geometry, maintain moisture balance, protect the wound surface, and eliminate dead space. NovaQuis Health, the sponsor named in the dvm360 article and podcast, says it is commercializing technologies across veterinary and human wellness markets under a One Health strategy. Those descriptions help explain why the modality was highlighted, but they should still be read as manufacturer claims unless backed by published comparative data. (dvm360.com)
From a clinical standpoint, the more durable takeaway may be the reminder that advanced wound care still depends on fundamentals. The MSD Veterinary Manual notes that primary dressings should protect tissue and maintain an optimal moist environment, while different categories serve different purposes: hydrogels add moisture to dry or necrotic wounds, foams absorb substantial exudate, alginates are suited to exudative wounds, and microcurrent dressings may shorten the inflammatory phase and support angiogenesis and re-epithelialization. The same source also warns that bandage complications, including maceration, pressure injury, and tissue necrosis, can undermine healing when technique or dressing choice is off. (msdvetmanual.com)
Why it matters: For veterinarians, technicians, and referral teams, this kind of education is useful because wound management often sits at the intersection of surgery, emergency medicine, dermatology, and client communication. A stage-based framework can help teams standardize how they assess progression, identify wounds that are no longer following an expected healing trajectory, and justify when a more advanced dressing or matrix is worth the added cost. It also reinforces that outcomes depend not just on the wound bed, but on the whole care system around it: pain control, contamination management, bandage intervals, recheck discipline, and what a pet parent can realistically carry out at home. (dvm360.com)
There’s also an industry angle worth watching. The Fetch content arrives as veterinary wound care companies increasingly position hydrogels, extracellular matrix products, and other regenerative platforms as workflow-friendly tools for general practice and specialty settings. That may expand options for clinicians, but it also raises the bar for evidence. Practices will likely want clearer head-to-head data on healing time, complication rates, bandage frequency, and adherence before deciding which advanced modalities truly change outcomes rather than simply add another line item to care. This is an inference based on the product positioning and the educational framing of the session. (dvm360.com)
What to watch: The next signal will be whether this conference discussion leads to published case series, comparative studies, or broader clinical guidance on where advanced matrices and adjunctive dressings fit in the wound-healing timeline, particularly for chronic wounds, dead space management, and difficult-to-bandage patients. (dvm360.com)